JEHSX Holdings — Health Sciences Trust
All 175 reported holdings of Health Sciences Trust (JEHSX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly and Company | 10.20% | $23.19M |
| Thermo Fisher Scientific Inc. | 4.12% | $9.36M |
| Intuitive Surgical Inc. | 3.71% | $8.42M |
| Stryker Corporation | 3.52% | $8.00M |
| Merck and Co. Inc. | 3.48% | $7.90M |
| AstraZeneca PLC | 3.22% | $7.32M |
| UnitedHealth Group Incorporated | 3.13% | $7.12M |
| argenx SE | 2.99% | $6.80M |
| AbbVie Inc. | 2.88% | $6.55M |
| Regeneron Pharmaceuticals Inc. | 2.69% | $6.11M |
| Gilead Sciences Inc. | 2.64% | $6.01M |
| Johnson and Johnson | 2.47% | $5.62M |
| Vertex Pharmaceuticals Incorporated | 2.46% | $5.59M |
| Danaher Corporation | 2.08% | $4.73M |
| Alnylam Pharmaceuticals Inc. | 1.68% | $3.82M |
| Ascendis Pharma A/S | 1.45% | $3.30M |
| United Therapeutics Corporation | 1.43% | $3.26M |
| Revolution Medicines Inc. | 1.39% | $3.16M |
| BeOne Medicines Ltd | 1.23% | $2.80M |
| Protagonist Therapeutics Inc. | 1.17% | $2.65M |
| Roivant Sciences Ltd. | 1.16% | $2.64M |
| Insmed Incorporated | 1.11% | $2.52M |
| Summit Therapeutics Inc. | 1.09% | $2.49M |
| Natera Inc. | 1.06% | $2.41M |
| Tenet Healthcare Corporation | 1.03% | $2.35M |
| Amgen Inc. | 1.03% | $2.34M |
| BrightSpring Health Services Inc. | 1.01% | $2.30M |
| Boston Scientific Corporation | 0.95% | $2.15M |
| HCA Healthcare Inc. | 0.92% | $2.10M |
| Guardant Health Inc. | 0.92% | $2.10M |
| CVS Health Corporation | 0.90% | $2.04M |
| Kymera Therapeutics Inc. | 0.81% | $1.84M |
| The Cigna Group | 0.78% | $1.78M |
| CG Oncology Inc. | 0.72% | $1.63M |
| Cardinal Health Inc. | 0.71% | $1.62M |
| Elevance Health Inc. | 0.68% | $1.55M |
| Krystal Biotech Inc. | 0.68% | $1.54M |
| Scholar Rock Holding Corporation | 0.65% | $1.47M |
| BridgeBio Pharma Inc. | 0.64% | $1.45M |
| Ionis Pharmaceuticals Inc. | 0.64% | $1.45M |
| Chugai Pharmaceutical Co. Ltd. | 0.61% | $1.38M |
| Praxis Precision Medicines Inc. | 0.61% | $1.38M |
| Structure Therapeutics Inc. | 0.60% | $1.36M |
| Celcuity Inc. | 0.59% | $1.35M |
| Royalty Pharma plc | 0.58% | $1.33M |
| Centessa Pharmaceuticals plc | 0.55% | $1.25M |
| Cencora Inc. | 0.54% | $1.24M |
| Vera Therapeutics Inc. | 0.48% | $1.10M |
| Nuvalent Inc. | 0.46% | $1.05M |
| Apogee Therapeutics Inc. | 0.46% | $1.04M |
| Edwards Lifesciences Corporation | 0.45% | $1.02M |
| Incyte Corporation | 0.44% | $1.01M |
| Abivax SA | 0.44% | $1.00M |
| Rowe T Price Gov Res Fd 20340919 00000.0000000000 | 0.43% | $986.09K |
| Spyre Therapeutics Inc. | 0.43% | $982.77K |
| Cytokinetics Incorporated | 0.43% | $971.51K |
| Dianthus Therapeutics Inc. | 0.41% | $941.25K |
| Crinetics Pharmaceuticals Inc. | 0.41% | $921.73K |
| Madrigal Pharmaceuticals Inc. | 0.39% | $874.72K |
| Immunome Inc. | 0.38% | $865.81K |
| IQVIA Holdings Inc. | 0.36% | $817.06K |
| Kodiak Sciences Inc. | 0.36% | $812.49K |
| Belite Bio Inc | 0.34% | $765.31K |
| Monte Rosa Therapeutics Inc. | 0.33% | $742.32K |
| Terns Pharmaceuticals Inc. | 0.32% | $729.70K |
| Mirum Pharmaceuticals Inc. | 0.30% | $686.38K |
| Axsome Therapeutics Inc. | 0.29% | $669.49K |
| Moderna Inc. | 0.28% | $636.98K |
| Alignment Healthcare Inc. | 0.27% | $606.02K |
| Beam Therapeutics Inc. | 0.26% | $595.99K |
| Alumis Inc. | 0.26% | $590.58K |
| IDEXX Laboratories Inc. | 0.25% | $577.62K |
| Revvity Inc. | 0.25% | $566.84K |
| Sionna Therapeutics Inc. | 0.25% | $564.67K |
| Sonova Holding AG | 0.24% | $547.92K |
| MBX Biosciences Inc. | 0.23% | $530.17K |
| West Pharmaceutical Services Inc. | 0.23% | $526.34K |
| McKesson Corporation | 0.23% | $526.14K |
| ORIC Pharmaceuticals Inc. | 0.23% | $519.62K |
| Rhythm Pharmaceuticals Inc. | 0.22% | $506.60K |
| State Street Bank and Trust Company | 0.22% | $500.00K |
| Immunocore Holdings plc | 0.22% | $496.09K |
| Rapport Therapeutics Inc. | 0.22% | $492.38K |
| Arrowhead Pharmaceuticals Inc. | 0.22% | $491.63K |
| Nurix Therapeutics Inc. | 0.21% | $486.14K |
| Caris Life Sciences Inc. | 0.21% | $479.76K |
| Erasca Inc. | 0.20% | $462.75K |
| Oruka Therapeutics Inc. | 0.20% | $447.34K |
| BillionToOne Inc. | 0.19% | $442.30K |
| Centene Corporation | 0.19% | $437.11K |
| Vaxcyte Inc. | 0.19% | $435.71K |
| Bio-Rad Laboratories Inc. | 0.19% | $428.44K |
| Palvella Therapeutics Inc. | 0.18% | $420.44K |
| MoonLake Immunotherapeutics | 0.18% | $398.62K |
| Encompass Health Corporation | 0.17% | $381.21K |
| Relay Therapeutics Inc. | 0.16% | $363.09K |
| BeOne Medicines Ltd | 0.16% | $360.52K |
| Kestra Medical Technologies Ltd | 0.15% | $350.75K |
| Wave Life Sciences Ltd. | 0.15% | $347.15K |
| Charles River Laboratories International Inc. | 0.15% | $345.35K |
| Repligen Corporation | 0.15% | $344.39K |
| Bicara Therapeutics Inc. | 0.15% | $340.82K |
| Novo Nordisk A/S | 0.15% | $339.57K |
| Disc Medicine Inc. | 0.15% | $334.98K |
| Celldex Therapeutics Inc. | 0.15% | $333.38K |
| Molina Healthcare Inc. | 0.14% | $327.12K |
| Stoke Therapeutics Inc. | 0.14% | $325.60K |
| Tarsus Pharmaceuticals Inc. | 0.14% | $316.38K |
| Sartorius Aktiengesellschaft | 0.14% | $314.27K |
| Replimune Group Inc. | 0.14% | $313.93K |
| Allogene Therapeutics Inc. | 0.14% | $307.14K |
| Cogent Biosciences Inc. | 0.14% | $307.30K |
| Tango Therapeutics Inc | 0.13% | $299.16K |
| Corvus Pharmaceuticals Inc. | 0.13% | $290.33K |
| Viatris Inc. | 0.12% | $281.01K |
| Kyverna Therapeutics Inc. | 0.12% | $277.14K |
| Denali Therapeutics Inc. | 0.12% | $270.01K |
| Ocular Therapeutix Inc. | 0.12% | $269.35K |
| Biohaven Ltd. | 0.12% | $266.57K |
| Climb Bio Inc. | 0.12% | $265.78K |
| Tyra Biosciences Inc. | 0.12% | $264.27K |
| IDEAYA Biosciences Inc. | 0.12% | $261.96K |
| Olema Pharmaceuticals Inc. | 0.11% | $260.24K |
| Pharvaris N.V. | 0.11% | $251.40K |
| Immunocore Holdings plc | 0.11% | $248.43K |
| Medpace Holdings Inc. | 0.11% | $240.09K |
| Shattuck Labs Inc. | 0.10% | $233.41K |
| Iovance Biotherapeutics Inc. | 0.10% | $232.32K |
| Generate Biomedicines Inc. | 0.10% | $227.93K |
| Liquidia Corporation | 0.10% | $219.31K |
| Cullinan Therapeutics Inc. | 0.10% | $215.99K |
| Lantheus Holdings Inc. | 0.09% | $204.79K |
| Procept Biorobotics Corporation | 0.09% | $199.78K |
| Atrium Therapeutics Inc. | 0.09% | $199.21K |
| Viridian Therapeutics Inc. | 0.08% | $170.74K |
| Zai Lab Limited | 0.07% | $162.26K |
| Xencor Inc. | 0.07% | $158.94K |
| Sensorion | 0.07% | $155.12K |
| SpyGlass Pharma Inc. | 0.07% | $155.25K |
| Entrada Therapeutics Inc. | 0.06% | $146.92K |
| Inspire Medical Systems Inc. | 0.06% | $144.42K |
| Immatics N.V. | 0.06% | $137.76K |
| Alto Neuroscience Inc. | 0.06% | $132.63K |
| Evommune Inc. | 0.06% | $127.62K |
| Aktis Oncology Inc. | 0.05% | $121.81K |
| Bicycle Therapeutics plc | 0.05% | $118.79K |
| Agios Pharmaceuticals Inc. | 0.05% | $110.62K |
| Crescent Biopharma Inc. | 0.05% | $109.47K |
| Immuneering Corporation | 0.04% | $91.47K |
| BridgeBio Oncology Therapeutics Inc. | 0.04% | $87.58K |
| Rocket Pharmaceuticals Inc. | 0.04% | $84.26K |
| Tectonic Therapeutic Inc. | 0.04% | $83.46K |
| Eikon Therapeutics Inc. | 0.03% | $76.29K |
| Annexon Inc. | 0.03% | $74.53K |
| Aura Biosciences Inc. | 0.03% | $69.75K |
| Immix Biopharma Inc. | 0.03% | $65.59K |
| Hims and Hers Health Inc. | 0.02% | $47.75K |
| Monopar Therapeutics Inc. | 0.02% | $47.34K |
| Enliven Therapeutics Inc. | 0.02% | $47.04K |
| Saluda Medical Inc. | 0.02% | $45.70K |
| Immunovant Inc. | 0.02% | $44.71K |
| RadNet Inc. | 0.02% | $40.91K |
| MediWound Ltd | 0.02% | $36.84K |
| Adlai Nortye Ltd. | 0.01% | $32.99K |
| LENZ Therapeutics Inc. | 0.01% | $31.72K |
| Beta Bionics Inc. | 0.01% | $26.24K |
| Nuvation Bio Inc. | 0.01% | $21.33K |
| Janux Therapeutics Inc. | 0.01% | $21.00K |
| Tenax Therapeutics Inc. | 0.01% | $19.22K |
| Ginkgo Bioworks Holdings Inc. | 0.01% | $12.08K |
| Revolution Medicines Inc. | 0.00% | $7.83K |
| Cabaletta Bio Inc. | 0.00% | $5.87K |
| Contra Generation Bio Common Stock | 0.00% | $3.95K |
| GeneDx Holdings Corp. | 0.00% | $39 |
| SomaLogic Inc. | 0.00% | $11 |
JEHSX overview: performance, fees, allocation and SEC filings